Skip to main content

Photo of smiling woman, wearing a blue blouse

Erica Sparkenbaugh, PhD was awarded a one-year Stage 1 SBIR grant from NHLBI (HL169107-01) titled Allosteric Modulation of PAR1 for the Treatment of Sickle Cell Disease.  She is a subcontract on the grant with Chris Dockendorff at Function Therapeutics as PI.